News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
229 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17912)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (331)
2 (134)
3 (3)
4 (4)
5 (239)
6 (297)
7 (254)
8 (229)
9 (142)
10 (7)
11 (9)
12 (228)
13 (282)
14 (268)
15 (254)
16 (160)
17 (2)
18 (5)
19 (218)
20 (259)
21 (132)
22 (18)
23 (29)
24 (4)
25 (14)
26 (221)
27 (273)
28 (265)
29 (229)
30 (119)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Drug Development
ArQule to Host Analyst Call Highlighting Clinical Progress from Ongoing Phase 1 Study of Reversible BTK Inhibitor, ARQ 531, in Patients with Relapsed/Refractory Hematologic Malignancies
ArQule, Inc. today announced that it will host a call to discuss the updated safety, PK, biomarker and anti-tumor activity data from the company’s Phase 1 dose escalation study in patients with relapsed or refractory hematologic malignancies (ARQ 531-101) that are being presented in a poster presentation at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition on December 3, 2018 in San Diego.
November 29, 2018
·
5 min read
Business
Visioneering Technologies Inc. Appoints Dr. Peg Achenbach as Vice President, Professional Services and Clinical Science
Achenbach brings depth and breadth of vision care expertise to VTI as it expands globally
November 29, 2018
·
3 min read
Deals
AgeX Therapeutics, Inc. Shares Commence Trading on the NYSE American
Company’s Common Stock Listed Under Symbol “AGE”
November 29, 2018
·
4 min read
FSD Pharma and SciCann Therapeutics to Present at the iCDP Summit in Boston
Summit speakers and participants will discuss issues such as complex Cannabinoid pharmacology, formulations and delivery systems, clinical studies, patient education and commercial challenges.
November 29, 2018
·
5 min read
Genetown
MIT Sloan to host conference on leveraging analytics for a proactive health system
Event will focus on using technology innovations to benefit all participants
November 29, 2018
·
4 min read
Business
Encompass Health announces plans to build its first inpatient rehabilitation hospital in South Dakota
Patient care expected to begin in the summer of 2020
November 29, 2018
·
4 min read
Student-led projects address mental health concerns in communities across Canada
The Co-operators has partnered with Enactus Canada to fund student projects focused on youth mental health.
November 29, 2018
·
3 min read
Biotech Beach
BIOLASE and Dallas Mavericks Announce a Partnership to Raise Awareness of Advanced Dental Care in the Community
BIOLASE encourages fans to celebrate the partnership with #GameDayGrin social media sweepstakes
November 29, 2018
·
3 min read
BioMidwest
New National Research Shows Most U.S. Students Feel Unprepared Without Social and Emotional Skills
Released today, a report titled Respected: Perspectives of Youth on High School & Social and Emotional Learning, shows that more than three-quarters (77 percent) of recent high school students believe their schools could have done a better job of helping students develop key social and emotional learning (SEL) skills
November 29, 2018
·
6 min read
Biotech Bay
New Analysis of NSABP Randomized B-20 Study Confirms Patients with Oncotype DX Breast Recurrence Score® Results Greater Than 25 Have Life-saving Substantial Benefit from Chemotherapy, Reinforcing the Conclusions of the Landmark TAILORx Study
Published Results Underscore Value of Oncotype DX® Test in Identifying Women with Early-stage Breast Cancer Who May Receive Life-saving Benefit from Chemotherapy
November 29, 2018
·
6 min read
Previous
15 of 23
Next